Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammation01:38

Inflammation

61.7K
Overview
61.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

12.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
12.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

493
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
493
Inflammatory Response01:28

Inflammatory Response

16.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.0K
Autoimmune Disorders01:29

Autoimmune Disorders

1.5K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autoantibody associations in patients with early diffuse cutaneous systemic sclerosis: the prospective registry of early systemic sclerosis.

Seminars in arthritis and rheumatism·2026
Same author

Fibrosing myopathy in systemic sclerosis: Treatment response and clinical outcomes in a distinct subset.

Seminars in arthritis and rheumatism·2026
Same author

Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement.

Seminars in arthritis and rheumatism·2026
Same author

Anorectal Dysfunction in Systemic Sclerosis: Clinical Phenotypes and Functional Patterns.

Arthritis care & research·2026
Same author

Unlocking multi-institutional insights into disease progression with PEAL as a lossless, one-shot federated learning solution.

NPJ digital medicine·2026
Same author

A 10-Year Comprehensive, Single-Center, Retrospective Analysis on Juxtapleural Nodules: Insights into Classification and Risk.

Diagnostics (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jan 18, 2026

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
12:23

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model

Published on: April 24, 2020

20.9K

Evaluating Hip Osteoarthritis as a Risk Factor for Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis.

Rebecca Fitzpatrick1, Shadpour Demehri2, Joseph Murray3

  • 1R. Fitzpatrick, MD, C.O. Bingham III, MD, A.A. Shah, MD, MHS, L.C. Cappelli, MD, MHS, MS, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore.

The Journal of Rheumatology
|January 15, 2026
PubMed
Summary

Hip osteoarthritis (OA) does not increase the risk of developing checkpoint inhibitor-induced inflammatory arthritis (ICI-IA) in lung cancer patients. However, ICI-IA was linked to reduced mortality in this study.

Keywords:
arthritisinflammationosteoarthritis

More Related Videos

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

721
Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective
06:14

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

Published on: January 12, 2024

2.6K

Related Experiment Videos

Last Updated: Jan 18, 2026

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
12:23

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model

Published on: April 24, 2020

20.9K
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

721
Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective
06:14

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

Published on: January 12, 2024

2.6K

Area of Science:

  • Oncology
  • Rheumatology
  • Radiology

Background:

  • Checkpoint inhibitor therapy is a crucial treatment for various cancers.
  • Immune-related adverse events, including inflammatory arthritis, are common side effects.
  • The role of pre-existing conditions like hip osteoarthritis in developing these adverse events is not well understood.

Purpose of the Study:

  • To investigate if hip osteoarthritis is a risk factor for checkpoint inhibitor-induced inflammatory arthritis (ICI-IA).

Main Methods:

  • Retrospective analysis of thoracic cancer patients treated with ICI therapy.
  • CT scans were used to assess hip osteoarthritis (Kellgren-Lawrence grade ≥2).
  • ICI-IA incidence and overall survival were compared between patients with and without hip OA using statistical models.

Main Results:

  • 103 out of 309 patients had hip OA on CT scans.
  • The incidence of ICI-IA did not significantly differ between patients with and without hip OA (p=0.78).
  • Higher BMI was associated with a lower hazard of ICI-IA (HR 0.93, p=0.049), while ICI-IA and higher BMI were associated with improved survival.

Conclusions:

  • CT-identified hip osteoarthritis is not a significant risk factor for developing ICI-IA in lung cancer patients.
  • ICI-IA was associated with decreased mortality in this patient cohort.
  • Further research may explore other contributing factors to ICI-IA development.